World's Best Scientists 2026 revealed!
Peter A. Andreasen

Peter A. Andreasen

D-Index & Metrics

Biology and Biochemistry

D-Index
69
Citations
22189
World Ranking
7278
National Ranking
64

Overview

Peter A. Andreasen was affiliated with Aarhus University in Denmark and worked within the broad field of Medicine, focusing specifically on Hematology and Internal Medicine. Their research contributions covered topics related to Blood Coagulation and Thrombosis Mechanisms as well as Venous Thromboembolism Diagnosis and Management.

Their published research included the paper titled "Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis", which appeared in 2020 in the journal Biomedicine & Pharmacotherapy.

Frequent coauthors in their work included:

  • Dong Wang
  • Yongshuai Yang
  • Yu Wang
  • Valérie Proulle
  • Wanjin Hong

Their publications were mostly found in the venue Biomedicine & Pharmacotherapy.

Research by Peter A. Andreasen addressed key mechanisms in hematology, particularly focusing on the pathological processes involving thrombosis and coagulation. Their investigations into the management and diagnosis of venous thromboembolism contributed to the broader understanding within internal medicine.

Best Publications

  • Plasminogen activators, tissue degradation, and cancer.

    K Danø;P A Andreasen;J Grøndahl-Hansen;P Kristensen

  • THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER METASTASIS: A REVIEW

    Peter A. Andreasen;Lars Kjøller;Lise Christensen;Michael J. Duffy

  • The plasminogen activation system in tumor growth, invasion, and metastasis.

    P. A. Andreasen;R. Egelund;H. H. Petersen

  • Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.

    A Nykjaer;C M Petersen;B Møller;P H Jensen

  • Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.

    Marikki Laiho;Olli Saksela;Olli Saksela;Peter A. Andreasen;Jorma Keski-Oja;Jorma Keski-Oja

  • Plasminogen activator inhibitors: hormonally regulated serpins

    Peter A. Andreasen;Birgitte Georg;Leif R. Lund;Andrea Riccio

  • cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

    D Ginsburg;R Zeheb;A Y Yang;U M Rafferty

  • UROKINASE-PLASMINOGEN ACTIVATOR, A NEW AND INDEPENDENT PROGNOSTIC MARKER IN BREAST CANCER

    Michael J. Duffy;David Reilly;Cathriona O'Sullivan;Niall O'Higgins

  • Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

    J Pöllänen;O Saksela;EM Salonen;P Andreasen

  • Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.

    P A Andreasen;L S Nielsen;P Kristensen;J Grøndahl-Hansen

  • The Urokinase Receptor Is a Major Vitronectin-Binding Protein on Endothelial Cells

    Sandip M. Kanse;Christine Kost;Olaf G. Wilhelm;Peter A. Andreasen

  • Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.

    L. R. Lund;A. Riccio;P. A. Andreasen;L. S. Nielsen

  • Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.

    Lars Kjøller;Sandip M. Kanse;Tove Kirkegaard;Kees W. Rodenburg

  • Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

    P.A. Andreasen;A. Riccio;K.G. Welinder;R. Douglas

  • Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor

    M V Cubellis;P Andreasen;P Ragno;M Mayer

  • Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes.

    S K Moestrup;S Nielsen;P Andreasen;K E Jørgensen

  • Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis

    Michelle K.V. Durand;Julie S. Bødker;Anni Christensen;Daniel M. Dupont

  • Urokinase receptor. An activation antigen in human T lymphocytes.

    A Nykjaer;B Møller;R F Todd;T Christensen

  • Receptor‐mediated endocytosis of plasminogen activators and activator/inhibitor complexes

    Peter A. Andreasen;Lars Sottrup-Jensen;Lars Kjøller;Anders Nykjær

  • Human endothelial cells contain one type of plasminogen activator

    Peter Kristensen;Lars-Inge Larsson;Lars S. Nielsen;Lars S. Nielsen;Jan Grøndahl-Hansen;Jan Grøndahl-Hansen

Frequent Co-Authors

Mingdong Huang
Mingdong Huang Fuzhou University
Keld Danø
Keld Danø Copenhagen University Hospital
Leif R. Lund
Leif R. Lund University of Copenhagen
Andrea Riccio
Andrea Riccio University of Campania "Luigi Vanvitelli"
Knud J. Jensen
Knud J. Jensen University of Copenhagen
Jørgen Gliemann
Jørgen Gliemann Aarhus University
Anders Nykjaer
Anders Nykjaer Aarhus University
Paul Declerck
Paul Declerck KU Leuven
Michael Ploug
Michael Ploug University of Copenhagen
Michael J. Duffy
Michael J. Duffy University College Dublin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Peter A. Andreasen